Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project

Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress. These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress. The latter can alter metabolite intermediates in the Krebs cycle leading to the format...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2020-10, Vol.172, p.106124-106124, Article 106124
Hauptverfasser: González, J., Gracia-Lavedan, E., Pamplona, R., Fernández, E., Lecube, A., de-Torres, J.P., Barbé, F., Torres, G., Benabdelhak, Ikram, Bermúdez, Marcelino, Castro, Eva, de Batlle, Jordi, Colàs-Campàs, Laura, Hernández, Marta, Jové, Mariano, Miquel, Eva, Martínez, Montserrat
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106124
container_issue
container_start_page 106124
container_title Respiratory medicine
container_volume 172
creator González, J.
Gracia-Lavedan, E.
Pamplona, R.
Fernández, E.
Lecube, A.
de-Torres, J.P.
Barbé, F.
Torres, G.
Benabdelhak, Ikram
Bermúdez, Marcelino
Castro, Eva
de Batlle, Jordi
Colàs-Campàs, Laura
Hernández, Marta
Jové, Mariano
Miquel, Eva
Martínez, Montserrat
description Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress. These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress. The latter can alter metabolite intermediates in the Krebs cycle leading to the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination). Protein succination has not been described in airways diseases. To assess differences in levels of AGEs and 2SC between patients with AO and normal spirometry. and Methods: In this case-control study, we investigated 35 moderate to severe AO patients and 31 subjects with normal spirometry, matched for age, gender, body mass index (BMI), tobacco history, prediabetes and adherence to Mediterranean diet. Plasma 2SC and AGEs concentrations were measured by GS/MS, and AGEs in skin were determined measuring autofluorescence (SAF). Multivariate logistic regression models explored the association between AGEs in the skin, 2SC and the presence of AO. The population was predominantly middle-age (mean of 58.7 years-old), overweight (median of BMI 26.7 kg/m2) and male subjects (69.7%). Patients with AO showed higher values of SAF (p = 0.04) and 2SC (p = 0.047). No differences were observed for plasma AGEs. SAF and 2SC were significantly associated with the presence of AO after adjusting for age, gender, smoking history, BMI and Mediterranean diet score (p = 0.041 and p = 0.038, respectively). Skin AGEs and 2SC are increased in patients with moderate to severe AO and independently associated with its presence. Further studies should confirm these findings and explore their potential role as a biomarker for the disease. •Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress.•These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress.•This leads the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination).•S-(2-succino) cysteine (2SC) levels and AGE skin levels are increased in moderate to severe AO patients.•These molecules have a potential role as biomarkers for AO.
doi_str_mv 10.1016/j.rmed.2020.106124
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2442219841</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S095461112030264X</els_id><sourcerecordid>2442219841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-76868a971a178c6c90b251626cb524113d2cd3af15e40f94ffc7be5fd89a744e3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EEqXwB5gssbCk-BzHSSQWVPElVYKhzJbjXMAhjYudFPXf46hMDEwn3T3v2fcQcglsAQzkTbvwG6wXnPGpIYGLIzKDLOVJyqQ4JjNWZiKRAHBKzkJoGWOlEGxG9Kt3A9qehtEY2-vBup7qQDXdxn4_WN3FkffuXQ9IK-s22n-ip66h2vpvvaeuCoMfzRRc0PUHUtuh38UVW-9aNMM5OWl0F_Dit87J28P9evmUrF4en5d3q8SIHIYkl4UsdJmDhrww0pSs4hlILk2VcQGQ1tzUqW4gQ8GaUjSNySvMmroodS4EpnNyfdgb3_0aMQxqY4PBrtM9ujEoLgTnUBYCInr1B23d6Pv4u4kqUsmKPIsUP1DGuxA8NmrrbTx_r4Cpybpq1WRdTdbVwXoM3R5CGE_dWfQqGIu9wdr6KEPVzv4X_wFGHotS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2448360875</pqid></control><display><type>article</type><title>Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project</title><source>Elsevier ScienceDirect Journals Complete</source><source>EZB Electronic Journals Library</source><creator>González, J. ; Gracia-Lavedan, E. ; Pamplona, R. ; Fernández, E. ; Lecube, A. ; de-Torres, J.P. ; Barbé, F. ; Torres, G. ; Benabdelhak, Ikram ; Bermúdez, Marcelino ; Castro, Eva ; de Batlle, Jordi ; Colàs-Campàs, Laura ; Hernández, Marta ; Jové, Mariano ; Miquel, Eva ; Martínez, Montserrat</creator><creatorcontrib>González, J. ; Gracia-Lavedan, E. ; Pamplona, R. ; Fernández, E. ; Lecube, A. ; de-Torres, J.P. ; Barbé, F. ; Torres, G. ; Benabdelhak, Ikram ; Bermúdez, Marcelino ; Castro, Eva ; de Batlle, Jordi ; Colàs-Campàs, Laura ; Hernández, Marta ; Jové, Mariano ; Miquel, Eva ; Martínez, Montserrat ; the ILERVAS Study Group</creatorcontrib><description>Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress. These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress. The latter can alter metabolite intermediates in the Krebs cycle leading to the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination). Protein succination has not been described in airways diseases. To assess differences in levels of AGEs and 2SC between patients with AO and normal spirometry. and Methods: In this case-control study, we investigated 35 moderate to severe AO patients and 31 subjects with normal spirometry, matched for age, gender, body mass index (BMI), tobacco history, prediabetes and adherence to Mediterranean diet. Plasma 2SC and AGEs concentrations were measured by GS/MS, and AGEs in skin were determined measuring autofluorescence (SAF). Multivariate logistic regression models explored the association between AGEs in the skin, 2SC and the presence of AO. The population was predominantly middle-age (mean of 58.7 years-old), overweight (median of BMI 26.7 kg/m2) and male subjects (69.7%). Patients with AO showed higher values of SAF (p = 0.04) and 2SC (p = 0.047). No differences were observed for plasma AGEs. SAF and 2SC were significantly associated with the presence of AO after adjusting for age, gender, smoking history, BMI and Mediterranean diet score (p = 0.041 and p = 0.038, respectively). Skin AGEs and 2SC are increased in patients with moderate to severe AO and independently associated with its presence. Further studies should confirm these findings and explore their potential role as a biomarker for the disease. •Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress.•These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress.•This leads the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination).•S-(2-succino) cysteine (2SC) levels and AGE skin levels are increased in moderate to severe AO patients.•These molecules have a potential role as biomarkers for AO.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2020.106124</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Advanced glycation end-products ; Advanced glycosylation end products ; Age ; Airway management ; Apoptosis ; Biobanks ; Biomarkers ; Body mass ; Body mass index ; Body size ; Body weight ; Cardiovascular disease ; Cholesterol ; Chronic illnesses ; Chronic obstructive pulmonary disease ; Chronology ; Creatinine ; Cysteine ; Diabetes ; Diet ; Emphysema ; Glycosylation ; Hemoglobin ; Hypoxemia ; Intermediates ; Kidney diseases ; Krebs cycle ; Lung diseases ; Metabolites ; Mitochondria ; Mitochondrial metabolic stress ; Overweight ; Oxidative stress ; Proteins ; Questionnaires ; Regression analysis ; Respiratory tract ; S-(2-succino) cysteine ; Skin ; Skin autofluorescence ; Spirometry ; Systemic inflammation ; Tobacco ; Tricarboxylic acid cycle</subject><ispartof>Respiratory medicine, 2020-10, Vol.172, p.106124-106124, Article 106124</ispartof><rights>2020 Elsevier Ltd</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-76868a971a178c6c90b251626cb524113d2cd3af15e40f94ffc7be5fd89a744e3</citedby><cites>FETCH-LOGICAL-c471t-76868a971a178c6c90b251626cb524113d2cd3af15e40f94ffc7be5fd89a744e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rmed.2020.106124$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>González, J.</creatorcontrib><creatorcontrib>Gracia-Lavedan, E.</creatorcontrib><creatorcontrib>Pamplona, R.</creatorcontrib><creatorcontrib>Fernández, E.</creatorcontrib><creatorcontrib>Lecube, A.</creatorcontrib><creatorcontrib>de-Torres, J.P.</creatorcontrib><creatorcontrib>Barbé, F.</creatorcontrib><creatorcontrib>Torres, G.</creatorcontrib><creatorcontrib>Benabdelhak, Ikram</creatorcontrib><creatorcontrib>Bermúdez, Marcelino</creatorcontrib><creatorcontrib>Castro, Eva</creatorcontrib><creatorcontrib>de Batlle, Jordi</creatorcontrib><creatorcontrib>Colàs-Campàs, Laura</creatorcontrib><creatorcontrib>Hernández, Marta</creatorcontrib><creatorcontrib>Jové, Mariano</creatorcontrib><creatorcontrib>Miquel, Eva</creatorcontrib><creatorcontrib>Martínez, Montserrat</creatorcontrib><creatorcontrib>the ILERVAS Study Group</creatorcontrib><title>Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project</title><title>Respiratory medicine</title><description>Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress. These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress. The latter can alter metabolite intermediates in the Krebs cycle leading to the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination). Protein succination has not been described in airways diseases. To assess differences in levels of AGEs and 2SC between patients with AO and normal spirometry. and Methods: In this case-control study, we investigated 35 moderate to severe AO patients and 31 subjects with normal spirometry, matched for age, gender, body mass index (BMI), tobacco history, prediabetes and adherence to Mediterranean diet. Plasma 2SC and AGEs concentrations were measured by GS/MS, and AGEs in skin were determined measuring autofluorescence (SAF). Multivariate logistic regression models explored the association between AGEs in the skin, 2SC and the presence of AO. The population was predominantly middle-age (mean of 58.7 years-old), overweight (median of BMI 26.7 kg/m2) and male subjects (69.7%). Patients with AO showed higher values of SAF (p = 0.04) and 2SC (p = 0.047). No differences were observed for plasma AGEs. SAF and 2SC were significantly associated with the presence of AO after adjusting for age, gender, smoking history, BMI and Mediterranean diet score (p = 0.041 and p = 0.038, respectively). Skin AGEs and 2SC are increased in patients with moderate to severe AO and independently associated with its presence. Further studies should confirm these findings and explore their potential role as a biomarker for the disease. •Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress.•These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress.•This leads the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination).•S-(2-succino) cysteine (2SC) levels and AGE skin levels are increased in moderate to severe AO patients.•These molecules have a potential role as biomarkers for AO.</description><subject>Advanced glycation end-products</subject><subject>Advanced glycosylation end products</subject><subject>Age</subject><subject>Airway management</subject><subject>Apoptosis</subject><subject>Biobanks</subject><subject>Biomarkers</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Body weight</subject><subject>Cardiovascular disease</subject><subject>Cholesterol</subject><subject>Chronic illnesses</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Chronology</subject><subject>Creatinine</subject><subject>Cysteine</subject><subject>Diabetes</subject><subject>Diet</subject><subject>Emphysema</subject><subject>Glycosylation</subject><subject>Hemoglobin</subject><subject>Hypoxemia</subject><subject>Intermediates</subject><subject>Kidney diseases</subject><subject>Krebs cycle</subject><subject>Lung diseases</subject><subject>Metabolites</subject><subject>Mitochondria</subject><subject>Mitochondrial metabolic stress</subject><subject>Overweight</subject><subject>Oxidative stress</subject><subject>Proteins</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>Respiratory tract</subject><subject>S-(2-succino) cysteine</subject><subject>Skin</subject><subject>Skin autofluorescence</subject><subject>Spirometry</subject><subject>Systemic inflammation</subject><subject>Tobacco</subject><subject>Tricarboxylic acid cycle</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EEqXwB5gssbCk-BzHSSQWVPElVYKhzJbjXMAhjYudFPXf46hMDEwn3T3v2fcQcglsAQzkTbvwG6wXnPGpIYGLIzKDLOVJyqQ4JjNWZiKRAHBKzkJoGWOlEGxG9Kt3A9qehtEY2-vBup7qQDXdxn4_WN3FkffuXQ9IK-s22n-ip66h2vpvvaeuCoMfzRRc0PUHUtuh38UVW-9aNMM5OWl0F_Dit87J28P9evmUrF4en5d3q8SIHIYkl4UsdJmDhrww0pSs4hlILk2VcQGQ1tzUqW4gQ8GaUjSNySvMmroodS4EpnNyfdgb3_0aMQxqY4PBrtM9ujEoLgTnUBYCInr1B23d6Pv4u4kqUsmKPIsUP1DGuxA8NmrrbTx_r4Cpybpq1WRdTdbVwXoM3R5CGE_dWfQqGIu9wdr6KEPVzv4X_wFGHotS</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>González, J.</creator><creator>Gracia-Lavedan, E.</creator><creator>Pamplona, R.</creator><creator>Fernández, E.</creator><creator>Lecube, A.</creator><creator>de-Torres, J.P.</creator><creator>Barbé, F.</creator><creator>Torres, G.</creator><creator>Benabdelhak, Ikram</creator><creator>Bermúdez, Marcelino</creator><creator>Castro, Eva</creator><creator>de Batlle, Jordi</creator><creator>Colàs-Campàs, Laura</creator><creator>Hernández, Marta</creator><creator>Jové, Mariano</creator><creator>Miquel, Eva</creator><creator>Martínez, Montserrat</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>202010</creationdate><title>Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project</title><author>González, J. ; Gracia-Lavedan, E. ; Pamplona, R. ; Fernández, E. ; Lecube, A. ; de-Torres, J.P. ; Barbé, F. ; Torres, G. ; Benabdelhak, Ikram ; Bermúdez, Marcelino ; Castro, Eva ; de Batlle, Jordi ; Colàs-Campàs, Laura ; Hernández, Marta ; Jové, Mariano ; Miquel, Eva ; Martínez, Montserrat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-76868a971a178c6c90b251626cb524113d2cd3af15e40f94ffc7be5fd89a744e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Advanced glycation end-products</topic><topic>Advanced glycosylation end products</topic><topic>Age</topic><topic>Airway management</topic><topic>Apoptosis</topic><topic>Biobanks</topic><topic>Biomarkers</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Body weight</topic><topic>Cardiovascular disease</topic><topic>Cholesterol</topic><topic>Chronic illnesses</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Chronology</topic><topic>Creatinine</topic><topic>Cysteine</topic><topic>Diabetes</topic><topic>Diet</topic><topic>Emphysema</topic><topic>Glycosylation</topic><topic>Hemoglobin</topic><topic>Hypoxemia</topic><topic>Intermediates</topic><topic>Kidney diseases</topic><topic>Krebs cycle</topic><topic>Lung diseases</topic><topic>Metabolites</topic><topic>Mitochondria</topic><topic>Mitochondrial metabolic stress</topic><topic>Overweight</topic><topic>Oxidative stress</topic><topic>Proteins</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>Respiratory tract</topic><topic>S-(2-succino) cysteine</topic><topic>Skin</topic><topic>Skin autofluorescence</topic><topic>Spirometry</topic><topic>Systemic inflammation</topic><topic>Tobacco</topic><topic>Tricarboxylic acid cycle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>González, J.</creatorcontrib><creatorcontrib>Gracia-Lavedan, E.</creatorcontrib><creatorcontrib>Pamplona, R.</creatorcontrib><creatorcontrib>Fernández, E.</creatorcontrib><creatorcontrib>Lecube, A.</creatorcontrib><creatorcontrib>de-Torres, J.P.</creatorcontrib><creatorcontrib>Barbé, F.</creatorcontrib><creatorcontrib>Torres, G.</creatorcontrib><creatorcontrib>Benabdelhak, Ikram</creatorcontrib><creatorcontrib>Bermúdez, Marcelino</creatorcontrib><creatorcontrib>Castro, Eva</creatorcontrib><creatorcontrib>de Batlle, Jordi</creatorcontrib><creatorcontrib>Colàs-Campàs, Laura</creatorcontrib><creatorcontrib>Hernández, Marta</creatorcontrib><creatorcontrib>Jové, Mariano</creatorcontrib><creatorcontrib>Miquel, Eva</creatorcontrib><creatorcontrib>Martínez, Montserrat</creatorcontrib><creatorcontrib>the ILERVAS Study Group</creatorcontrib><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>González, J.</au><au>Gracia-Lavedan, E.</au><au>Pamplona, R.</au><au>Fernández, E.</au><au>Lecube, A.</au><au>de-Torres, J.P.</au><au>Barbé, F.</au><au>Torres, G.</au><au>Benabdelhak, Ikram</au><au>Bermúdez, Marcelino</au><au>Castro, Eva</au><au>de Batlle, Jordi</au><au>Colàs-Campàs, Laura</au><au>Hernández, Marta</au><au>Jové, Mariano</au><au>Miquel, Eva</au><au>Martínez, Montserrat</au><aucorp>the ILERVAS Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project</atitle><jtitle>Respiratory medicine</jtitle><date>2020-10</date><risdate>2020</risdate><volume>172</volume><spage>106124</spage><epage>106124</epage><pages>106124-106124</pages><artnum>106124</artnum><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress. These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress. The latter can alter metabolite intermediates in the Krebs cycle leading to the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination). Protein succination has not been described in airways diseases. To assess differences in levels of AGEs and 2SC between patients with AO and normal spirometry. and Methods: In this case-control study, we investigated 35 moderate to severe AO patients and 31 subjects with normal spirometry, matched for age, gender, body mass index (BMI), tobacco history, prediabetes and adherence to Mediterranean diet. Plasma 2SC and AGEs concentrations were measured by GS/MS, and AGEs in skin were determined measuring autofluorescence (SAF). Multivariate logistic regression models explored the association between AGEs in the skin, 2SC and the presence of AO. The population was predominantly middle-age (mean of 58.7 years-old), overweight (median of BMI 26.7 kg/m2) and male subjects (69.7%). Patients with AO showed higher values of SAF (p = 0.04) and 2SC (p = 0.047). No differences were observed for plasma AGEs. SAF and 2SC were significantly associated with the presence of AO after adjusting for age, gender, smoking history, BMI and Mediterranean diet score (p = 0.041 and p = 0.038, respectively). Skin AGEs and 2SC are increased in patients with moderate to severe AO and independently associated with its presence. Further studies should confirm these findings and explore their potential role as a biomarker for the disease. •Airway obstruction (AO) is associated with hypoxemia, systemic inflammation and oxidative stress.•These conditions can favor the formation of Advanced Glycation End-products (AGEs) and induce mitochondrial stress.•This leads the formation of the cysteine-fumarate adduct S-(2-succino) cysteine (2SC) in proteins (protein succination).•S-(2-succino) cysteine (2SC) levels and AGE skin levels are increased in moderate to severe AO patients.•These molecules have a potential role as biomarkers for AO.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.rmed.2020.106124</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2020-10, Vol.172, p.106124-106124, Article 106124
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_miscellaneous_2442219841
source Elsevier ScienceDirect Journals Complete; EZB Electronic Journals Library
subjects Advanced glycation end-products
Advanced glycosylation end products
Age
Airway management
Apoptosis
Biobanks
Biomarkers
Body mass
Body mass index
Body size
Body weight
Cardiovascular disease
Cholesterol
Chronic illnesses
Chronic obstructive pulmonary disease
Chronology
Creatinine
Cysteine
Diabetes
Diet
Emphysema
Glycosylation
Hemoglobin
Hypoxemia
Intermediates
Kidney diseases
Krebs cycle
Lung diseases
Metabolites
Mitochondria
Mitochondrial metabolic stress
Overweight
Oxidative stress
Proteins
Questionnaires
Regression analysis
Respiratory tract
S-(2-succino) cysteine
Skin
Skin autofluorescence
Spirometry
Systemic inflammation
Tobacco
Tricarboxylic acid cycle
title Protein succination as a potential surrogate biomarker of airway obstruction. The ilervas project
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A27%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein%20succination%20as%20a%20potential%20surrogate%20biomarker%20of%20airway%20obstruction.%20The%20ilervas%20project&rft.jtitle=Respiratory%20medicine&rft.au=Gonz%C3%A1lez,%20J.&rft.aucorp=the%20ILERVAS%20Study%20Group&rft.date=2020-10&rft.volume=172&rft.spage=106124&rft.epage=106124&rft.pages=106124-106124&rft.artnum=106124&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2020.106124&rft_dat=%3Cproquest_cross%3E2442219841%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2448360875&rft_id=info:pmid/&rft_els_id=S095461112030264X&rfr_iscdi=true